thank you very much mrs hina good afternoon ladies and gentlemen and thank you for joining us again for this press briefing. first of all i want to start by stating that our safety committee the pharmacovigilance and risk assessment committee of the european medicines agency has confirmed that the benefits of the astra zeneca vaccine in preventing covert 19 overall outweigh the risks of side effects kovac 19 is a very serious disease with high hospitalized patients and that creates an every day covert is still causing thousands of that across the e.u. this vaccine has proven to be highly effective it prevents if severe disease and hospitalization and it is saving lives vaccination is extremely important in helping us in the fight against cope at 19 and we need to use the vaccines we have to protect us from the devastating effects of the pride after an very in-depth analysis has concluded that the reported cases of unusual blood clotting following vaccination with the astra zeneca vaccine should be listed as possible side effects of the vaccine. as we communicated last week we convened a